We downgraded National Vision Holdings stock to hold due to lack of near-term growth and need for tangible evidence. Read more on EYE stock here.

The drug, a low-dose atropine, was being tested with the company's experimental drug-delivery device, Optejet, as a potential ...

Thanks to constant innovations, diagnostics and decision-making have become faster and easier than ever for eye care ...

Report Ocean has published a new report on the Ophthalmological Devices Market, delivering an extensive analysis of key factors such as market restraints, drivers, and opportunities. The report offers ...

Diabetes can have a huge impact on eye health, with Optical Express revealing that diabetic retinopathy is the leading cause ...